Caucasian Americans have higher mesothelioma mortality rates.
According to the National Cancer Institute, Caucasian Americans have significantly higher mesothelioma mortality rates than other races. This mortality rate disparity is primarily due to the different treatment options available for patients. In addition to standard treatments like chemotherapy, patients with mesothelioma often undergo more aggressive treatments such as lung resection or thymectomy.
Mesothelioma is a disease most commonly affected by exposure to asbestos. While only a small percentage of asbestos-exposed individuals develop the disease, it is common among older people. Genetics may play a role, but researchers are still unsure of the exact nature of the genetic link. The U.S. SEER Cancer Data show that Caucasian men and women have higher mesothelioma diagnosis rates than other groups. This may be due to their higher representation in occupations with high asbestos exposure.
The latency period for mesothelioma is approximately 10 to 50 years. It is important to note that men are more likely to develop the disease than women, and men are more likely to be exposed to the material during their lifetime.
The number of mesothelioma deaths in the United States was over 2,000 per year from 1999 to 2020. The age-adjusted mortality rate was 4.83 per million women. However, the number of deaths among women is expected to rise as women’s life expectancy increases.
Although there are some improvements in the treatment of mesothelioma, this disease is still the leading cause of death in older white men. It also affects men of all ages and racial groups. The mortality rate is still the highest among Caucasian Americans, but it will likely decline in the future.
While men are more likely to develop mesothelioma than women, Caucasian Americans are four to five times more likely to develop it than other races. The Northern United States also has the highest mesothelioma mortality rate. Ninety-five percent of mesothelioma patients are white, and the other five percent of cases are unknown.
Overall, survival rates for mesothelioma patients are improving thanks to new research and treatment. Some patients with poor prognoses have survived for several years after diagnosis. And the survival rates of both peritoneal and pleural mesothelioma patients increased in the last five years. It’s important to note that survival rates are often confused with life expectancy, measured in years.
Age-adjusted death rates may be contributing.
To understand the trends in mesothelioma mortality, it is necessary to look at mortality rates by age group. Although the rates have declined overall, they have increased in certain age groups, such as those aged 60 and over. In some countries, the age-adjusted mortality rate has remained stable or decreased. In other countries, the rate has increased.
The study looked at deaths related to malignant mesothelioma from 1999 to 2020. They used CDC WONDER Multiple Cause of Death data to compile mortality statistics. The study focused on deaths of women over 25 years and age-adjusted the death rate to the standard U.S. population of 2000. Researchers then used the Joinpoint Regression Program+ statistical software to analyze time-trends of deaths.
The study’s results indicate that the incidence rate of malignant mesothelioma among women has risen by 25 percent over the last decade. Age-adjusted death rates (EAPC) for the ASIR were negatively correlated in 1990 and positively correlated in 2017. The correlation between age-adjusted death rates and the SDI level was reversed in countries with high mesothelioma mortality rates.
The overall mortality rate for malignant mesothelioma among women increased by 25 percent from 1999 to 2020. The age-adjusted death rate was 4.83 per million women in 1999 and decreased to 4.15 per million women in 2020. Women in the health care industry and those in the homemaker occupation had the highest mortality rate.
Age-adjusted death rates showed that men in some regions had higher incidence rates than women in the 1980s and 1990s. However, the age composition of incident cases varied between regions, with 65.0% of patients over 70 years in Australasia.
Age-adjusted death rates of patients in the US and UK were higher than those in Europe and Australia. The data in the Global Burden of Disease Study 2017 were based on point estimates and were calculated 1000 times. The data were derived from 195 countries and 21 regions. Patients were included in the study if they were between 15 and 49 years old.